Sort
30,917 grants matching “tumor microenvironment”
ATG16L1 isoforms and CRC health disparities
$399,187Paul Dent · Virginia Commonwealth University · R21 · FY2024 · CA
Targeting DDX3 for triple-negative breast cancer treatment
$399,129Venu Raman · Johns Hopkins University · R21 · FY2025 · CA
Regulation of the tumor microenvironment by DNA damage repair proteins
$399,094Svasti Haricharan · San Diego State University · R37 · FY2024 · CA
POTENTIATING BREAST CANCER THERAPIES BY TARGETING TUMOR-ASSOCIATED MACROPHAGE
$399,073Suzie H Pun · University Of Washington · R01 · FY2016 · CA
SBIR TOPIC 403 PHASE I: DEVELOPMENT OF SPATIAL MICRO-PURIFICATION TECHNOLOGY
$399,062Michael Emmert-Buck · Avoneaux Medical Institute, Llc · N01 · FY2020 · CA
Core 1: Tumor and Microenvironment Heterogeneity Core (TMH Core)
$399,061Susan M Kaech · Salk Institute For Biological Studies · P01 · FY2024 · CA
Role of type 2 immune response in pancreatic cancer tumorigenesis
$399,058Prasenjit Dey · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
PROTAC Targeting of Tip60 in Syngeneic Cancer Models Using Cereblon Knock-in Mice
$399,051Wayne William Hancock · Children'S Hosp Of Philadelphia · R01 · FY2021 · CA
Single-cell and imaging data integration software to spatially resolve the tumor microenvironment
$399,041Elana Fertig · Johns Hopkins University · U01 · FY2022 · CA
Optimizing Therapeutic STING Agonism in Triple Negative Breast Cancer
$399,032Thanh Uyen Barbie · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Antigen-independent prediction and biomarker identification of cancer-specific T cells
$399,032Bo Li · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA
Distinct Tumor and Metastatic Collagen Microenvironments: Divergent Targeting Approaches
$399,013Keith Syson Chan · Cedars-Sinai Medical Center · R01 · FY2020 · CA
The B7x pathways in the tumor microenvironment
$399,000Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2025 · CA
Advancing cancer therapy: Developing antibody blockade targeting a novel immune checkpoint, LAIR1/CD305
$398,997Jianping Huang · Immunogenik, Inc. · R41 · FY2025 · CA
Research Testbed 1
$398,992Paolo Provenzano · University Of Minnesota · U54 · FY2023 · CA
Exploiting gold nanoparticle as a probe to identify therapeutic targets
$398,989Priyabrata Mukherjee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · CA
Project 1: Elucidating the genetics and cell of origin of pancreatic cancer initiation
$398,988Laura D Attardi · Stanford University · P01 · FY2022 · CA
Project 1:Evolutionary dynamics and drivers of breast cancer metastasis and relapse
$398,968Christina N Curtis · Stanford University · U54 · FY2022 · CA
Nanotherapeutic treatment of the invasive glioblastoma microenvironment
$398,967Graeme F Woodworth · University Of Maryland Baltimore · R01 · FY2023 · NS
Deciphering Mechanisms of Tumor-Stromal Interactions in Prostate Cancer
$398,952Boyang Wu · Washington State University · R01 · FY2021 · CA
N-cadherin in Extraskeletal Osteolineage Cells Modulates Tumor Growth
$398,949Roberto Civitelli · Washington University · R01 · FY2021 · CA
The B7x pathways in the tumor microenvironment
$398,901Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2021 · CA
TBEL Project 3
$398,880Laura Delong Wood · University Of Tx Md Anderson Can Ctr · U54 · FY2022 · CA
Arming Oncolytic HSV Vectors to Induce Anti-GBM Immune Responses in Syngeneic Mice
$398,871Joseph C. Glorioso · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Human cytomegalovirus-induced alterations to cell-surface adhesion proteins
$398,800Thomas E Shenk · Princeton University · R01 · FY2017 · AI